President: Yi-Hsiang Huang
Secretary General: I-Cheng Lee
| President | Secretary General | ||
|---|---|---|---|
| 6th | 2020-2023 | Shi-Ming Lin | Chen-Chun Lin |
| 5th | 2017-2020 | Shi-Ming Lin | Chen-Chun Lin |
| 4th | 2014-2017 | Chung-Kwe Wang | Kuan-Yang Chen |
| 3rd | 2012-2014 | Chung-Kwe Wang | Kuan-Yang Chen |
| 2nd | 2010-2012 | Pao-Huei Chen | Chung-Kwe Wang |
| 1st | 2008-2010 | Pao-Huei Chen | Chung-Kwe Wang |
The History and Mission of the Taiwan Liver Cancer Association (TLCA)
The origins of the Taiwan Liver Cancer Association (TLCA) trace back to July 2003, when the Taiwan Liver Cancer Study Group was established by the visionary Dr. Chung-Kwe Wang. After five years of close collaboration and scientific exchanges among its dedicated members, the group recognized the critical need for a formal national entity, leading to the official founding of the TLCA in May 2008.
Today, the TLCA boasts a vibrant, multidisciplinary community of over 400 members. This diverse network includes leading hepatologists, hepatobiliary surgeons, pathologists, interventional radiologists, radiation oncologists, medical oncologists, and basic science researchers—all united in the fight against liver cancer.
Our Leadership Legacy
The association’s growth has been guided by a legacy of distinguished leadership:
1st & 2nd Terms (2008–2012): Prof. Pao-Huei Chen
3rd & 4th Terms (2012–2017): Prof. Chung-Kwe Wang
5th & 6th Terms (2017–2023): Prof. Shi-Ming Lin
7th Term (2023–2027): Prof. Yi-Hsiang Huang (Current President)
Under the active leadership of President Yi-Hsiang Huang, the TLCA has significantly expanded its international footprint. The association signed a landmark Memorandum of Understanding (MOU) with the Japan Liver Cancer Association (JLCA) in October 2024, followed by an MOU with the Korean Liver Cancer Association (KLCA) in January 2026, cementing powerful regional alliances in East Asia.
Core Missions of the TLCA:
Advance Clinical Care: Continuously update and improve the diagnosis, treatment, and prevention of liver cancer.
Knowledge Exchange: Facilitate the sharing of clinical techniques and advanced management strategies for hepatocellular carcinoma (HCC).
Foster Research: Promote and support groundbreaking basic and translational research in hepatology.
Global Collaboration: Partner with internationally renowned scholars and host world-class scientific symposiums.
